FTSE 100 Falls Sharply as Financial and Mining Stocks Lead Broad Market Decline

FTSE 100

The FTSE 100 fell notably in midday London trading on Wednesday, with the index at 10,086.88, down 218.41 points (2.12%), as widespread selling across financial and mining stocks weighed heavily on the benchmark.

The decline reflects a broad-based move lower across UK equities, with risk sentiment weakening as investors reduce exposure to cyclical and commodity-linked sectors.

Energy Stocks Provide Limited Support

Energy stocks were among the few areas of strength during the session. BP led the risers, supported by firmer oil prices, while Centrica also traded slightly higher.

Defensive consumer names such as Imperial Brands showed marginal gains, although the overall strength in these sectors was limited.

Top Risers

  • BP. – BP Plc up 2.70% to 570.80p
  • CNA – Centrica plc up 0.33% to 211.65p
  • IMB – Imperial Brands Group up 0.06% to 3,129.00p

These gains were not sufficient to offset broader market weakness.

Financial and Mining Stocks Lead the Sell-Off

Selling pressure was concentrated in financials and mining stocks, which were among the worst performers during the session.

Fresnillo recorded the steepest decline, reflecting weakness in precious metals sentiment. Banking group NatWest and asset manager M&G also fell sharply, highlighting pressure across the financial sector.

Mining company Endeavour Mining added to the downside, underlining weakness across resource stocks.

Top Fallers

The scale of these declines reflects a broad risk-off move across key sectors of the index.

Currency and Macro Context

Sterling traded relatively steady against both the euro and US dollar, suggesting currency movements were not the primary driver of today’s decline.

Instead, the sell-off appears linked to broader market sentiment, with investors reacting to global economic uncertainty, commodity price volatility and evolving expectations around interest rates.

Pound and Euro

The pound and the euro continue to trade within a relatively narrow range, as investors weigh weak growth signals against persistent inflation risks across both economies.

In the United Kingdom, recent data point to a loss of momentum. Monthly GDP figures show the economy stagnating at the start of the year, reinforcing the view that growth remains fragile. While the services sector continues to support activity, broader economic expansion has been limited.

Inflation remains above the Bank of England’s target, with the latest reading near 3%. Although policymakers expect inflation to ease in the coming months, recent increases in global energy prices introduce uncertainty into that outlook. Higher oil and gas costs could feed through to consumer prices later in the year.

The Bank of England has maintained a cautious stance, with internal divisions over the timing of future rate cuts. Some policymakers are increasingly focused on weak growth, while others remain concerned about underlying inflation pressures.

In the eurozone, inflation is closer to target, with recent estimates indicating a rate just below 2%. This has allowed the European Central Bank to adopt a more stable policy stance, although officials continue to emphasise the need for further data before making any policy adjustments.

Growth conditions in the euro area remain mixed. Industrial production has shown weakness, particularly in manufacturing, but business surveys suggest the wider economy continues to expand at a modest pace.

Purchasing Managers’ Index data highlight a divergence between the two regions. The UK continues to record stronger activity readings, driven largely by services, while the eurozone shows slower but still positive growth.

Energy markets remain a key factor for both currencies. Oil prices are holding near recent highs, and European gas prices have risen in recent weeks. These developments increase the risk of renewed inflation pressure and may influence central bank decisions in the months ahead.

Market Outlook

With the FTSE 100 falling towards the 10,000 level, the market is showing increased sensitivity to macroeconomic developments. The sharp decline highlights a shift towards risk reduction, particularly in financial and mining sectors, while selective strength in energy stocks provides limited support.

Share on:

Vietnam Enterprise Investments earnings strengthen as investor flows weigh on stocks

VEIL’s portfolio manager examines the disconnect between strong corporate earnings and weak share prices, and why easing inflation, improving liquidity and Vietnam’s FTSE upgrade could help narrow the gap.

Chesnara reports 79% rise in operating capital generation in H1 2026

Chesnara delivered strong first-half growth, with operating capital generation up 79% to £96m, adjusted operating profit rising 46% and the interim dividend increasing 6%.

Oxford Nanopore appoints David Miller as Chief Development and Product Officer

Oxford Nanopore Technologies has appointed David Miller as Chief Development and Product Officer and confirmed Conor McKechnie as Chief Marketing and Communications Officer. The new executive hires, both joining the leadership team this autumn, are intended to align product development, marketing and commercial execution as the company scales its differentiated technology platform.

Smiths Group appoints two independent Non-Executive Directors

Smiths Group has announced the appointment of Val Rahmani and Emma FitzGerald as independent non-executive directors, with committee changes also confirmed.

Melrose Industries announces claims programme and GKN Garden Grove restart target

Melrose Industries has outlined a claims programme, regulatory update and target date for full manufacturing operations at GKN Aerospace Garden Grove.

AstraZeneca strengthens funding position with €2.55 billion Eurobond issue

AstraZeneca has priced four tranches of Eurobonds totalling €2.55 billion, with closing expected on 1 September 2026.

Natural gas outlook strengthens as heat and LNG demand tighten market balance

US natural gas is entering a stronger seasonal setup as heat, slower storage growth and recovering LNG demand improve the market balance.

GSK gains priority FDA review for Jemperli in rectal cancer

GSK says the US FDA has accepted Jemperli for priority review in previously untreated stage II and III locally advanced rectal cancer.

Search

Search